“Dr. Rial and staff were very personable, efficient, and explained each procedure before it was done. I felt very at ease and that I was in professional & capable hands. Thank you for such good care.”
Can Steroids Cause Central Serous Chorioretinopathy?
How Steroid Medicines Are Linked to CSC
The link between steroids and CSC is one of the most consistent findings in the research on this condition. Multiple large reviews have found that people using steroids are significantly more likely to develop CSC than those who are not. Understanding that link, including which steroid types are involved and why, helps you and your care team make informed decisions.
A pooled analysis of six comparison studies, covering more than 700 steroid users and nearly 2,000 non-users, found that steroid use was associated with roughly four times the odds of developing CSC. A separate review of 17 studies and nearly 10,000 patients found a similar association. These are observational studies, meaning they show a strong, repeated connection rather than absolute cause-and-effect proof, but Retina Specialists treat the link as solid enough to guide clinical decisions.
This is not limited to steroid tablets. Reported cases of CSC have followed steroids taken by mouth, given by vein, sprayed in the nose, rubbed onto the skin, injected into a joint or near the spine, and applied around the eye. Nasal allergy sprays and over-the-counter skin creams are among the steroid exposures that Retina Specialists specifically ask about.
Pooled data found the link held clearly for oral steroids, injected steroids, and nasal sprays. The signal for inhaled steroids was less statistically clear, though that does not mean inhalers are confirmed safe for the eyes. It is a reason to list every steroid you use, not a reason to stop one you rely on.
Steroid medicines work by mimicking cortisol, a hormone your adrenal glands naturally produce. Cortisol influences blood vessel behavior and fluid balance throughout the body, including inside the eye. In CSC, steroid signaling appears to be one of the pathways that causes the choroid to become thickened and leaky and that disrupts the pump cells above it.
The same condition, CSC, has also been observed in people whose bodies produce too much of their own cortisol, such as those with Cushing disease, and in some pregnant women, when cortisol rises naturally. That parallel strengthens the case that cortisol, from any source, plays a meaningful role.
Steroids are the most consistently reported risk factor, but they are not the only one. Research has also found associations between CSC and high blood pressure, a stomach infection called Helicobacter pylori, poor or disrupted sleep, autoimmune conditions, certain psychiatric medications, and a driven or time-pressured personality style.
Other medications reported alongside CSC include stimulants, decongestants, erectile dysfunction treatments, and some cancer drugs. None of these factors makes a diagnosis by itself, but reviewing them with your doctor creates a fuller picture, especially if fluid keeps coming back.
Symptoms and Warning Signs
Most people with CSC notice a change in one eye rather than both, and the change is usually gradual and painless. Knowing what CSC typically feels like, and knowing which symptoms point to something more serious, helps you respond appropriately and quickly.
The most common descriptions are a blurry or dim patch in the center of one eye, a gray or washed-out area, straight lines that appear bent or wavy, and colors that look less vivid. Some people also notice that objects appear slightly smaller in the affected eye compared to the other.
The change usually develops over days and is not painful. If the eye also hurts or becomes red, that points to a different condition and deserves a same-day call to your eye clinic.
CSC linked to steroid use does not always follow the classic pattern. In a multicenter comparison of nearly 500 CSC patients, those with current or past steroid exposure were more likely to have both eyes involved, more leaking points, and a higher rate of recurrence. The typical male predominance was also less pronounced in steroid-linked cases.
This is one reason to be specific when describing your symptoms. If both eyes seem affected, or if fluid keeps returning, mention your steroid use clearly and bring a full list of every steroid product you use.
CSC is not a same-day emergency for most people. Other retinal conditions are, and you cannot tell them apart at home. Seek same-day care, or go to an emergency room if your eye clinic is closed, if you experience any of the following.
- A curtain or shadow moving across your vision from one side
- A sudden burst of new floaters or persistent flashing lights
- Sudden vision loss that comes on within seconds or minutes
- Severe eye pain, a red and painful eye, or sudden double vision
These symptoms point away from CSC and toward conditions where time matters. If you are uncertain, call your eye clinic and describe what you see. Phone triage is exactly what that call is for.
How CSC Is Diagnosed
Diagnosing CSC involves a combination of scanning technology and a thorough review of your medical history, including all medications. The process is straightforward, mostly painless, and gives your Retina Specialist the information needed to plan the right level of care.
The primary diagnostic tool is an OCT scan, which stands for optical coherence tomography. This test uses safe light waves to create a detailed cross-section image of the retina without touching the eye. The fluid blister beneath the retina appears clearly on the scan, confirming the diagnosis and allowing your Retina Specialist to measure the fluid at each follow-up visit to track whether it is clearing.
When the diagnosis is uncertain, when fluid has persisted for months, or when treatment is being planned, your Retina Specialist may order a dye test to locate exactly where fluid is leaking in. Fluorescein angiography shows the leaking point and produces a characteristic inkblot or smokestack pattern. Indocyanine green angiography reveals congestion in the choroid, the vessel layer behind the retina. Both tests involve injecting dye into a vein in the arm while a camera photographs your retina.
These tests are not needed for everyone. They are ordered when more information is required before making a treatment decision.
A thorough CSC workup always includes a complete review of every medicine you use, including products bought without a prescription. Nasal sprays, skin creams, injections for joints or the back, and any steroid applied around the eye are the ones people most often forget to mention.
Because CSC has been reported following steroids given by many different routes, your medication history is a genuine part of the diagnostic process. If another specialist prescribed your steroid, bringing that clinic's contact information allows your care teams to communicate directly.
Treatment Options for CSC
Treatment for CSC depends on how long the fluid has been present, how much it affects your vision, and whether a steroid can be safely adjusted. Many cases resolve without intervention, while others benefit from targeted procedures. Your Retina Specialist will weigh all of these factors before recommending a course of action.
For a sudden, first-time episode, watchful waiting is a well-supported clinical choice and not simply a delay. Most acute cases resolve within three to six months on their own, and evidence reviews support observation as the preferred approach for sudden CSC, with treatment reserved for long-lasting disease.
Observation still means being monitored. You should leave your appointment with a specific follow-up scan date and clear instructions about which changes would bring you back sooner.
When steroid use is identified, your Retina Specialist will typically raise the question of whether the steroid can be reduced, switched, or stopped, directing that conversation to the prescribing clinician. Reducing or discontinuing a steroid where medically appropriate is part of standard CSC management.
You should not stop or reduce a steroid on your own while waiting for your appointment. Stopping suddenly can prevent your body from producing enough of its own cortisol, a serious condition called adrenal insufficiency that can follow steroid use by any route, dose, or duration. Any changes to your steroid must be planned and monitored by the doctor who prescribed it. In some cases, the condition being treated with the steroid is serious enough that continuing it while monitoring the eye closely is the right answer.
When fluid persists beyond several months, the best-supported treatment is photodynamic therapy. A light-sensitive medication is given through a vein in the arm and then activated by a gentle, precisely aimed laser targeting the leaky area of the choroid. Evidence reviews name half-dose or half-fluence photodynamic therapy as the treatment of choice for chronic CSC.
In a well-conducted randomized trial of people with long-lasting CSC, fluid had cleared in roughly two-thirds of those who received half-dose photodynamic therapy, compared to roughly one-third of those treated with a different laser approach. Your Retina Specialist can tell you whether this treatment is available and appropriate for your situation.
Thermal laser directed at a leaking point away from the very center of the retina remains an option in specific cases, and micropulse laser, which uses gentler energy pulses, is used in some clinics. Both have roles in particular circumstances.
Oral medications have been studied with disappointing results. A large randomized trial found that the tablet eplerenone performed no better than a placebo for vision at twelve months. Across 25 randomized CSC treatment trials, no single approach demonstrated convincing superiority, and the certainty of evidence across those trials was rated mostly low. This is why your Retina Specialist balances how long fluid has been present against how much it affects your daily life before recommending any specific treatment.
Recovery and Long-Term Outlook
Most people with CSC recover meaningful vision as the fluid clears, but the timeline and final outcome vary. Knowing what to realistically expect, and what can go wrong if fluid lingers, helps you stay engaged in your follow-up care and recognize when to ask for more.
Vision loss in CSC is usually temporary, with improvement occurring over weeks to months as the fluid resolves. Many people return to near their previous level of sharpness. Some are left with mild residual dimness, slight distortion, or colors that appear slightly different in the affected eye even after the retina looks dry on a scan.
These lingering changes are common but usually mild. Follow-up imaging provides a more meaningful picture of your individual progress than any population average.
Recurrence is a real possibility. Population data suggest that roughly one in three people with CSC will have at least one recurrence, typically within about a year to a year and a half of the first episode. Some reports place recurrence rates even higher in untreated cases.
Cases linked to steroid exposure have been found to recur more often than cases without it. This makes ongoing attention to steroid use, and keeping follow-up appointments, particularly important for anyone who needs long-term steroid therapy.
When fluid persists over months without treatment, it can cause thinning and scarring of the retinal pump cell layer, allow abnormal blood vessels to grow beneath the retina, and lead to lasting vision reduction. This is the uncommon path, not the typical one, but it is the main reason chronic CSC is treated rather than simply observed indefinitely.
Regular follow-up scans are the most practical tool for catching persistent fluid early, before those changes have a chance to develop. Keeping your scheduled appointments is one of the most important things you can do.
Many people cannot stop their steroid because the condition it treats is serious or ongoing. That situation is manageable. Your prescribing physician and your Retina Specialist can work together to find the lowest effective dose or an alternative medication, and your eye team can schedule more frequent scans so that any persistence of fluid is caught early.
In the meantime, using brighter lighting for reading and being cautious with night driving while one eye is affected are practical steps. If your vision no longer meets the standard required for driving in your area, you have an obligation to report that to the relevant authority.
Frequently Asked Questions
These questions address practical decisions and clarifications that patients often raise after learning about the connection between steroids and CSC.
Vision often improves as fluid clears, and reducing or stopping the steroid where medically possible is a standard part of managing CSC. However, the outcome depends on how long fluid was present, whether any permanent changes occurred to the pump cell layer, and how the eye responds over time. The decision to adjust or stop any steroid belongs to the prescribing doctor, since the underlying condition it treats still needs to be managed. Setting realistic expectations with your Retina Specialist at your follow-up visits is more useful than any general estimate.
Yes, both are on the list of reported causes. Nasal allergy sprays showed a clear association with CSC in pooled research data, and skin creams, including some sold without a prescription, are specifically mentioned by Retina Specialists as exposures worth reporting. This is not a reason to stop a spray or cream that is controlling an important condition. It is a reason to include every steroid product you use, regardless of how minor it seems, when your eye history is reviewed. The route of delivery matters less than many patients assume.
Yes, and the earlier you raise it, the better. Steroid eye drops after cataract surgery serve a genuine purpose in controlling inflammation, and there are often ways to adjust the type, dose, or schedule of drops for someone with a CSC history. Bringing this up well before the surgery date, rather than on the day, gives your surgeon time to plan appropriately and to arrange a follow-up scan afterward if that seems advisable. Do not assume your surgical team already has this information from a different provider.
A simple home check is a practical habit, particularly if you are on a steroid or have had CSC before. Cover one eye and look at a straight line, such as a door frame or window edge, then swap eyes. Bowing of the line, a dim or gray patch, or any new distortion in the center of your vision is worth reporting to your eye clinic promptly. Your clinic may also provide an Amsler grid, a printed square of small lines designed for the same purpose. A home check is a prompt to call, not a substitute for a scan, but it can catch a change before your next scheduled visit.
Three to six months of persistent fluid is the clinical marker that separates a sudden episode from chronic CSC, and it is also the threshold at which evidence supports moving from observation to active treatment. If you are approaching that window and your scans still show fluid, it is entirely appropriate to ask your Retina Specialist what the next step is. You do not have to wait to be offered the conversation. Asking also gives you time to find out whether photodynamic therapy, the best-supported treatment for chronic CSC, is available at your clinic.
Both are recognized risk factors, and they may work through a shared pathway. Psychological stress raises cortisol, the same hormone family that steroid medicines mimic, which may mean the two act on the same mechanism in the eye. Research has found associations between CSC and poor sleep, a time-pressured personality style, and steroid use together, making it difficult to fully separate them in any individual case. Practically, a medication review with your prescribing doctor and attention to sleep quality are both reasonable and actionable steps, regardless of which factor is contributing more.
Visit Atlantic Retina Center for Expert Retinal Care
Atlantic Retina Center is a single-specialty practice dedicated entirely to the retina, vitreous, and macula, with fellowship-trained, board-certified Retina Specialists who have the experience and imaging technology to accurately diagnose and manage conditions like CSC. Whether you are newly experiencing central vision changes or managing a long-standing retinal condition while on steroid therapy, our team is equipped to guide you through your options with clarity and care. We welcome patients from across the Eastern Shore of Maryland and central and southern Delaware, and we are here to help you protect your vision with confidence.